Term
|
Definition
enzyme to sythesize cholesterol
inhibited by statins |
|
|
Term
|
Definition
produces only small increase in blood levels
inhibits endogenous cholesterol production |
|
|
Term
|
Definition
| produced by liver hepatocytes |
|
|
Term
|
Definition
component of all cell membranes and membranes of intracellular organisms
required for synthesis of certain hormones (reproductive) and bile salts
deposited in stratum corneum of skin |
|
|
Term
|
Definition
recog. sites for cell-surface receptors
activate enzyme that metabolize lipoprotiens
increases structural stability of lipoprotiens |
|
|
Term
| Low density lipoprotiens (LDL) |
|
Definition
| transport from liver to body periphery |
|
|
Term
| high density lipoprotiens (HDL) |
|
Definition
| take cholesterol from periphery where it is stored |
|
|
Term
| very low density lipoprotiens (VLDL) |
|
Definition
|
|
Term
|
Definition
| begins with transport of LDL's from arterial lumen into endothelial cells, then to the space underlying the arterial epithelium |
|
|
Term
|
Definition
Diabetes
inc. age
HTN
smoking
dec. HDL, inc. LDL
Family Hx |
|
|
Term
| adjunct Tx or High LDL cholesterol |
|
Definition
Therapeutic lifestyle changes
TLC diet
weight control
excercise
smoking cessation
Drugs should be used only if these fail |
|
|
Term
| HMG-CoA reductase inhibitors (statins) |
|
Definition
Atorvastatin (Lipitor)
most effective
reduces LDL
elevates HDL
Reduces triglycerides
Non lipid action: promotes plaque stability, reduces risk for CV event, inc. bone formation |
|
|
Term
| HMG-CoA R.I. therapeutic uses |
|
Definition
hypercholesterolemia
primary and secondary prevention of CV events
post MI therapy
diabetes?
dec. risk of stroke |
|
|
Term
| HMG-CoA R.I. adverse effects |
|
Definition
Common: HA, Rash, Gi disturb.
Rare: myopathy(muscle pain, weakness, tenderness)/rhabdomyolysis(muscle dissolves)
hepatotoxicity(monitor LFT, baseline, then 6-12 Months)
peripheral neuropathy
maybe connection with parkinsons |
|
|
Term
| Damage to liver, kidneys, and muscle |
|
Definition
| all inc. Creatinine level |
|
|
Term
| HMG-CoA R.I. drug interactions |
|
Definition
most lipid lowering drugs (except bile acid sequesterants)
Drugs that inhibit CYP3A4 (macrolide antibx, antifungals, |
|
|
Term
|
Definition
once daily in evening
greatest impact when given in evening because endogenous cholesterol syn. goes up in the night |
|
|
Term
nicotinic acid (niacin)
Niaspan (long acting niacin) |
|
Definition
Reduces LDL and TG levels (better at dec. TG)
inc. HDL more effectively than any other drug
dec. production of VLDL
|
|
|
Term
| nicotinic acid therapeutic uses |
|
Definition
lowering TG levels
mixed elevation of LDL's and TG's
used for low HDL's |
|
|
Term
| Nicotinic Acid adverse effects |
|
Definition
skin (flushing, itching): initially intense preTx w/ ASA
Gastrointestinal: hepatotoxicity
hyperglycemia
gouty arthritis
raise blood level of homocysteine (inc. risk for CHD) |
|
|
Term
|
Definition
Colesevelam (Welchol)
previously first line drugs but now adjunt to statins
reduction in LDL
inc. in VLDL (in some Pts)
not absorbed in GI, Binds with bile acids
also lowers LDL by inc. LDL receptors on hepatocytes |
|
|
Term
| Bile Acid Sequesterants adverse effects |
|
Definition
Constipation
does not decrease uptake of fat-soluble vitamins (as other bile sequesterants do)
does not significantly reduce absorprtion of statins, warfarin, or digoxin |
|
|
Term
| Fibric acid Derivatives (fibrates) |
|
Definition
most effective drugs for lowering TG levels
can raise HDL
Little to no effect on LDL
can inc. risk for bleeding for Pts on warfarin(watch PT-INR)
can inc. risk for rhabdomyolysis in Pts taking statins |
|
|
Term
|
Definition
Dec. plasma TG content
Lowers VLDL
Can raise HDL
ppar alpha? |
|
|
Term
| gemfibrozil drug interactions |
|
Definition
Displaces warfarin from plasma albumin
measure INR frequently |
|
|
Term
| Gemfibrozil Therapeutic uses |
|
Definition
reduces high levels of plasma triglycerides and VLDLs
less effective than statins in reducing LDL
can raise HDL (not approved for this) |
|
|
Term
| Gemfibrozil adverse effects |
|
Definition
rashes
GI disturb.
gallstones
myopathy
liver injury (hepatotoxic) |
|
|
Term
|
Definition
Ezetimibe (Zetia)
inhibits cholesterol absorption in small intestine
|
|
|
Term
| Ezetimibe therapeutic uses |
|
Definition
reducing total cholesterol, LDL, and apolipoprotien B
approved for monotherapy and combonation with statins (slightly inc. risk for liver damage) |
|
|
Term
| Ezetimibe adverse effects |
|
Definition
myopathy
rhabdomyolysis
hepatitis
pancreatitis
thrombocytopenia (watch platelets)
|
|
|
Term
| Ezetimibe drug interactions |
|
Definition
statins
fibrates
bile-acid sequesterants
cyclosporine |
|
|
Term
|
Definition
O2 supply to heart is insufficient to meet O2 demand
sudden pain beneath sternum, often radiating to left shoulder and arm |
|
|
Term
| two goals of angina drug therapy |
|
Definition
1. prevention of MI and death
2. prevention of myocaridial ishemia and anginal pain |
|
|
Term
| three families of antianginal agents |
|
Definition
1. organic nitrates (e.g. nitro, isosorbide (isordil))
2. CCB's (diltiazem, nifedipine)
3. BB's (propanolol, metoprolol) |
|
|
Term
| determinants of oxygen demand |
|
Definition
HR
myocardial contractility
intramyocardial wall tension (preload/afterload)
|
|
|
Term
| determinants of O2 supply |
|
Definition
myocardial blood flow
myocardial perfusion only in diastole |
|
|
Term
Chronic stable angina (exertional)
pathophysiology |
|
Definition
emotional excitement
large meals
cold exposure
coronary heart disease
|
|
|
Term
|
Definition
inc. cardiac O2 supply
dec. O2 demand |
|
|
Term
| chronic stable angina therapeutic agents |
|
Definition
organic nitrates
beta blockers
ccb's
ranolazine |
|
|
Term
| Variant angina (prinzmetal's-vasospastic) pathophysiology |
|
Definition
|
|
Term
|
Definition
|
|
Term
| variant angina therapeutic agents |
|
Definition
|
|
Term
|
Definition
|
|
Term
| unstable angina pathophysiology |
|
Definition
symptoms of angina at rest
new-onset exertional angina
intensification of existing angina |
|
|
Term
|
Definition
maintain O2 supply
dec. O2 demand |
|
|
Term
| unstable angina therapeutic agents |
|
Definition
| MONA therapy, BB's, heparin |
|
|
Term
|
Definition
Morphine
O2-4 liters (given first)
Nitro-contra hypotension
ASA
used for acute coronary syndrome |
|
|
Term
| time is takes for myocardium to die |
|
Definition
|
|
Term
| organic nitrates (nitroglycerin) |
|
Definition
works directly on vasc. smooth muscle for Venodilation
dec. cardiac workload
dec. pre/afterload= dec. O2 demand
inc. O2 supply |
|
|
Term
|
Definition
stable, variant, and unstable angina
vasodilator |
|
|
Term
|
Definition
HA (vasodilation of cerebral BV's)
orthostatic hypotention
reflex tachycardia |
|
|
Term
|
Definition
can develop rapidly
cross tolerance to all other nitrates
use lowest effective dose to minimize
long acting (isosorbide) for prophylaxis |
|
|
Term
|
Definition
hypotensive drugs
phosphodiesterase type5 inhibitors
BB's, verapamil, diltiazem |
|
|
Term
|
Definition
acute anginal therapy
sustained anginal therapy
IV for perioperative control of blood pressure, and Tx of heart failure with MI, unstable angina, and uncontrolled exacerbations of chronic angina |
|
|
Term
|
Definition
diltiazem(cardizem) and nifedipine(procardia)
blocks calcium channels in VSM
|
|
|
Term
|
Definition
| for stable and variant angina |
|
|
Term
|
Definition
reflex tachycardia (from hypotension)
dilation of peripheral arterioles
hypotension
bradycardia
heart failure
AV block |
|
|
Term
|
Definition
propanolol(inderol) and metoprolol(lopressor)
Dec. cardiac O2 demand |
|
|
Term
|
Definition
| for stable and unstable angina |
|
|
Term
|
Definition
bradycardia and hypotension
dec. AV conduction
reduction of contractility
asthmatic effects
depression insomnia and bizzare dreams
sexual dysfuntion |
|
|
Term
| revascularization therapy |
|
Definition
CABG
Percutaneous transluminal coronary angioplasty (PTCA) |
|
|
Term
| drugs used to prevent MI and death |
|
Definition
antiplatelet drugs
cholesterol lowering drugs
ACE inhibitors
antianginal agents |
|
|
Term
|
Definition
streptokinase(streptase): fibrinolytic, causes lysis of thrombus
Altepase (tPa) |
|
|
Term
| thrombolytic drugs adverse effects |
|
Definition
major: Bleeding (minor oozing to life threatening amount)
likely sites: recent wounds, needle pricks, invasive procedure sights
|
|
|
Term
| streptokinase (streptase) |
|
Definition
| binds to plasminogen to form active complex |
|
|
Term
| streptokinase therapeutic uses |
|
Definition
acute coronary thrombosis (acute MI)
Large deep venous thrombosis
massive pulmonary emboli |
|
|
Term
| streptokinase adverse effects |
|
Definition
bleeding- excessive fibrinolysis can be reversed with aminocaproic acid (amicar)
antibody production
hypotension
fever
intercranial hemorrhage |
|
|